Molecular Cancer Volume 3
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
Short communicationL1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomasLaura Menendez1 , Benedict B Benigno2 and John F McDonald1,2  1Department of Genetics, University of Georgia, Life Science Building, Athens, GA 30602, USA 2The Ovarian Cancer Institute, 1100 Johnson Ferry Road, Suite 510, Atlanta, GA, 30342, USA author email corresponding author email
Molecular Cancer 2004,
3:12doi:10.1186/1476-4598-3-12 Abstract
Wide-spread hypomethylation of CpG dinucleotides is characteristic of many cancers. Retrotransposons have been identified as potential targets of hypomethylation during cellular transformation. We report the results of an preliminary examination of the methylation status of CpG dinucleotides associated with the L1 and HERV-W retrotransposons in benign and malignant human ovarian tumors. We find a reduction in the methylation of CpG dinucleotides within the promoter regions of these retroelements in malignant relative to non-malignant ovarian tissues. Consistent with these results, we find that relative L1 and HERV-W expression levels are elevated in representative samples of malignant vs. non-malignant ovarian tissues. |